Andrew Welch , DO
Assistant Professor of Clinical
Medical Sciences Building
COM IM Endocrinology Division - 0547
Education
BS: Brigham Young University Provo, UT, 2013 (Neuroscience)
DO: Arizona College of Osteopathic Medicine Glendale, AZ, 2020
Certifications
American Board of Internal Medicine (Certification Date: 08-20-2020 )
American Board of Internal Medicine (Endocrinology-Diabetes and Metabolism) (Certification Date: 10-24-2023 )
Clinical Interests
Diabetes
Diabetes Mellitus
Diabetes Type 1 (Diabetes Mellitus, Type 1)
Diabetes Type 2 (Diabetes Mellitus, Type 2)
Diabetic Foot
Diabetic Hypoglycemia
Diabetic Ketoacidosis
Diabetic Nephropathy
Diabetic Neuropathies
Thyroid Cancer
Adrenal Insufficiency
Adrenocortical Adenoma
Cushing syndrome (Hypercortisolism)
Hyperparathyroidism
Hyperthyroidism
Hypothyroidism (Underactive thyroid)
Obesity
Osteoporosis
Pituitary Adenoma
Prolactinoma
Specialities
Endocrinology-Diabetes and Metabolism
Internal Medicine
Publications
Peer Reviewed Publications
Welch, Andrew A; Farahani, Rahele A; Egan, Aoife M; Laurenti, Marcello C; Zeini, Maya; Vella, Max; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara Dalla; Matveyenko, Aleksey; Vella, Adrian (2023. ) The effect of Glucagon-Like Peptide-1 Receptor blockade on islet secretion and glucose metabolism in humans.The Journal of clinical investigation, , More Information
Schembri Wismayer, Daniel; Laurenti, Marcello C; Song, Yilin; Egan, Aoife M; Welch, Andrew A; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara; Jensen, Michael D; Vella, Adrian (2023. ) Effects of acute changes in fasting glucose and free fatty acid concentrations on indices of β-cell function and glucose metabolism in subjects without diabetes.American journal of physiology. Endocrinology and metabolism, , 325 (2 ) ,E119-E131 More Information
Farahani, Rahele A; Egan, Aoife M; Welch, Andrew A; Laurenti, Marcello C; Cobelli, Claudio; Dalla Man, Chiara; Vella, Adrian (2023. ) The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion.Diabetes, , 72 (4 ) ,449-454 More Information
Brar, Gurkirat S; Barrow, Breanne M; Watson, Matthew; Griesbach, Ryan; Choung, Edwina; Welch, Andrew; Ruzsicska, Bela; Raleigh, Daniel P; Zraika, Sakeneh (2017. ) Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2).Diabetes, , 66 (8 ) ,2201-2212 More Information
Welch, Andrew A; Toro-Tobon, David; Rachmasari, Kharisa N; Sandooja, Rashi B; Rahimi, Leili; Mohan, Sneha; Hewlett, Jennifer R; Clark, Jennifer; Maheshwari, Arvind; Zhang, Catherine; Brito, Juan P (2024. ) Improving Intravenous and Subcutaneous Insulin Overlap During Treatment of Diabetic Ketoacidosis: A Quality Improvement Project.Mayo Clinic proceedings. Innovations, quality & outcomes, , 8 (3 ) ,293-300 More Information